Evidence map›Paper›PMID 33745185›Full record

ArticleDevelopmental dynamics : an official publication of the American Association of Anatomists2022

BMP/TGF-β signaling as a modulator of neurodegeneration in ALS.

Kathryn Russo, Kristi A Wharton

Open access · bronzeAbstract read
In one paragraph

Article in Developmental dynamics : an official publication of the American Association of Anatomists, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Dysregulation of BMP, Wnt, and Insulin Signaling in Fragile X Syndrome.Frontiers in cell and developmental biology · 2022
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Kathryn RussoDepartment of Neuroscience, Brown University, Providence, Rhode Island, USA.
Kristi A WhartonRobert J. and Nancy D. Carney Institute for Brain Science, Brown University, Providence, Rhode Island, USA.ORCID 0000-0001-9625-4336
Allen Institute for Brain Science · US

Funding

Interdisciplinary Predoctoral Neuroscience Training Program in the Neuroscience Graduate Program.T32MH020068 · NIMH · BROWN UNIVERSITY · PI LIPSCOMBE, DIANE, SHEINBERG, DAVID L · 1999 to 2025
$7.6M
Differential regulation of BMP Signals in VivoR01GM068118 · NIGMS · BROWN UNIVERSITY · PI WHARTON, KRISTI A · 2005 to 2014
$2.5M
Regulated energy metabolism in ALS/FTDRF1NS126667 · NINDS · BROWN UNIVERSITY · PI WHARTON, KRISTI A · 2022 to 2022
$1.2M
Differential regulation of BMP signals in vivo.R56GM068118 · NIGMS · BROWN UNIVERSITY · PI WHARTON, KRISTI A · 2009 to 2009
$352k
NIGMS NIH HHS GM068118NIGMS NIH HHS R01 GM068118NIGMS NIH HHS R56 GM068118NIMH NIH HHS T32 MH020068NINDS NIH HHS RF1 NS126667
6 · The paper itself

Abstract

This commentary focuses on the emerging intersection between BMP/TGF-β signaling roles in nervous system function and the amyotrophic lateral sclerosis (ALS) disease state. Future research is critical to elucidate the molecular underpinnings of this intersection of the cellular processes disrupted in ALS and those influenced by BMP/TGF-β signaling, including synapse structure, neurotransmission, plasticity, and neuroinflammation. Such knowledge promises to inform us of ideal entry points for the targeted modulation of dysfunctional cellular processes in an effort to abrogate ALS pathologies. It is likely that different interventions are required, either at discrete points in disease progression, or across multiple dysfunctional processes which together lead to motor neuron degeneration and death. We discuss the challenging, but intriguing idea that modulation of the pleiotropic nature of BMP/TGF-β signaling could be advantageous, as a way to simultaneously treat defects in more than one cell process across different forms of ALS.

Indexed as

Amyotrophic Lateral SclerosisDisease ProgressionHumansTransforming Growth Factor betaTransforming Growth Factor betaactin dynamicsALSamyotrophic lateral sclerosisBMP signalingimportin-βLIMKmadneurodegenerationnucleocytoplasmic transportp38/MAPKSmadTGF-β signaling

Identifiers

PMID33745185
PMCPMC11929146
OpenAlexW3137911761

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.